Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice Article Swipe
Aino Rajamäki
,
Marc Sorigué
,
Roosa Prusila
,
Milla E.L. Kuusisto
,
Hanne Kuitunen
,
Esa Jantunen
,
Santiago Mercadal
,
Taina Turpeenniemi‐Hujanen
,
Juan‐Manuel Sancho
,
Kaisa Sunela
,
Outi Kuittinen
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2340/1651-226x.2024.24377
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2340/1651-226x.2024.24377
Background: The modern-day therapeutic landscape for follicular lymphoma (FL) includes a number of highly effective therapies. Patients and methods: We set out to determine progression-free survival (PFS) after front line, second line, and third line of therapy on the basis of relevant biological characteristics and therapeutic choices. Patients (n = 743, 51% females, median 60 years old) diagnosed with grade 1–2 FL between 1997 and 2016 in nine institutions were included. Results: The median PFS1, PFS2, and PFS3 were 8.1 years (95% confidence interval [CI]: 7–9.3 years), 4.2 years (95% CI: 2.8–5.6 years) and 2.2 years (95% CI 1.7–2.8 years). We found longer PFS1 for (1) females, (2) younger age, (3) lower-risk follicular lymphoma international prognostic index (FLIPI), (4) standard intensity (over low intensity) regimens and (5) immunochemotherapy strategies and (6) maintenance rituximab. We found a shorter PFS2 for patients who received front-line immunochemotherapy. Older age at diagnosis correlated with a shorter PFS3. Intensity of front-line chemotherapy, maintenance, or POD24 status did not correlate with PFS2 or PFS3 in this dataset. Interpretation: With current immunochemotherapy strategies, the natural course of FL is characterized by shorter-lasting remissions after each relapse. It will be interesting to see whether new therapies can alter this pattern.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.2340/1651-226x.2024.24377
- https://medicaljournalssweden.se/actaoncologica/article/download/24377/46021
- OA Status
- diamond
- References
- 46
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4396676506
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4396676506Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2340/1651-226x.2024.24377Digital Object Identifier
- Title
-
Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practiceWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-05-06Full publication date if available
- Authors
-
Aino Rajamäki, Marc Sorigué, Roosa Prusila, Milla E.L. Kuusisto, Hanne Kuitunen, Esa Jantunen, Santiago Mercadal, Taina Turpeenniemi‐Hujanen, Juan‐Manuel Sancho, Kaisa Sunela, Outi KuittinenList of authors in order
- Landing page
-
https://doi.org/10.2340/1651-226x.2024.24377Publisher landing page
- PDF URL
-
https://medicaljournalssweden.se/actaoncologica/article/download/24377/46021Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://medicaljournalssweden.se/actaoncologica/article/download/24377/46021Direct OA link when available
- Concepts
-
Medicine, Follicular lymphoma, Front line, Oncology, Lymphoma, Internal medicine, Follicular phase, Second line, Progression-free survival, Line (geometry), Overall survival, First line, Mathematics, Geometry, Law, Political scienceTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
46Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4396676506 |
|---|---|
| doi | https://doi.org/10.2340/1651-226x.2024.24377 |
| ids.doi | https://doi.org/10.2340/1651-226x.2024.24377 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38709114 |
| ids.openalex | https://openalex.org/W4396676506 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000401 |
| mesh[1].descriptor_ui | D008224 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | mortality |
| mesh[1].descriptor_name | Lymphoma, Follicular |
| mesh[2].qualifier_ui | Q000188 |
| mesh[2].descriptor_ui | D008224 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | drug therapy |
| mesh[2].descriptor_name | Lymphoma, Follicular |
| mesh[3].qualifier_ui | Q000628 |
| mesh[3].descriptor_ui | D008224 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | therapy |
| mesh[3].descriptor_name | Lymphoma, Follicular |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D005260 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Female |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D008875 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Middle Aged |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D008297 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Male |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000368 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Aged |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000077982 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Progression-Free Survival |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000328 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Adult |
| mesh[10].qualifier_ui | Q000627 |
| mesh[10].descriptor_ui | D000971 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | therapeutic use |
| mesh[10].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000369 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Aged, 80 and over |
| mesh[12].qualifier_ui | Q000627 |
| mesh[12].descriptor_ui | D000069283 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | therapeutic use |
| mesh[12].descriptor_name | Rituximab |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D012189 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Retrospective Studies |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D055815 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Young Adult |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D011379 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Prognosis |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D006801 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Humans |
| mesh[17].qualifier_ui | Q000401 |
| mesh[17].descriptor_ui | D008224 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | mortality |
| mesh[17].descriptor_name | Lymphoma, Follicular |
| mesh[18].qualifier_ui | Q000188 |
| mesh[18].descriptor_ui | D008224 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | drug therapy |
| mesh[18].descriptor_name | Lymphoma, Follicular |
| mesh[19].qualifier_ui | Q000628 |
| mesh[19].descriptor_ui | D008224 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | therapy |
| mesh[19].descriptor_name | Lymphoma, Follicular |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D005260 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Female |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D008875 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Middle Aged |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D008297 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Male |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000368 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Aged |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D000077982 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Progression-Free Survival |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D000328 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Adult |
| mesh[26].qualifier_ui | Q000627 |
| mesh[26].descriptor_ui | D000971 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | therapeutic use |
| mesh[26].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D000369 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Aged, 80 and over |
| mesh[28].qualifier_ui | Q000627 |
| mesh[28].descriptor_ui | D000069283 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | therapeutic use |
| mesh[28].descriptor_name | Rituximab |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D012189 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Retrospective Studies |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D055815 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Young Adult |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D011379 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Prognosis |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D006801 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Humans |
| mesh[33].qualifier_ui | Q000401 |
| mesh[33].descriptor_ui | D008224 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | mortality |
| mesh[33].descriptor_name | Lymphoma, Follicular |
| mesh[34].qualifier_ui | Q000188 |
| mesh[34].descriptor_ui | D008224 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | drug therapy |
| mesh[34].descriptor_name | Lymphoma, Follicular |
| mesh[35].qualifier_ui | Q000628 |
| mesh[35].descriptor_ui | D008224 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | therapy |
| mesh[35].descriptor_name | Lymphoma, Follicular |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D005260 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Female |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D008875 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Middle Aged |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D008297 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Male |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D000368 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Aged |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D000077982 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Progression-Free Survival |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D000328 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Adult |
| mesh[42].qualifier_ui | Q000627 |
| mesh[42].descriptor_ui | D000971 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | therapeutic use |
| mesh[42].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D000369 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Aged, 80 and over |
| mesh[44].qualifier_ui | Q000627 |
| mesh[44].descriptor_ui | D000069283 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | therapeutic use |
| mesh[44].descriptor_name | Rituximab |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D012189 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Retrospective Studies |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D055815 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Young Adult |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D011379 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Prognosis |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D006801 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Humans |
| mesh[49].qualifier_ui | Q000401 |
| mesh[49].descriptor_ui | D008224 |
| mesh[49].is_major_topic | True |
| mesh[49].qualifier_name | mortality |
| mesh[49].descriptor_name | Lymphoma, Follicular |
| type | article |
| title | Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice |
| biblio.issue | |
| biblio.volume | 63 |
| biblio.last_page | 272 |
| biblio.first_page | 267 |
| topics[0].id | https://openalex.org/T10185 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Lymphoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T10550 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.998199999332428 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2743 |
| topics[1].subfield.display_name | Reproductive Medicine |
| topics[1].display_name | Ovarian cancer diagnosis and treatment |
| topics[2].id | https://openalex.org/T10685 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9965000152587891 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Viral-associated cancers and disorders |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.92855304479599 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2777058707 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8843040466308594 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q123251 |
| concepts[1].display_name | Follicular lymphoma |
| concepts[2].id | https://openalex.org/C2781403576 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6959500312805176 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q4384456 |
| concepts[2].display_name | Front line |
| concepts[3].id | https://openalex.org/C143998085 |
| concepts[3].level | 1 |
| concepts[3].score | 0.652834951877594 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[3].display_name | Oncology |
| concepts[4].id | https://openalex.org/C2779338263 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6028927564620972 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[4].display_name | Lymphoma |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5190427899360657 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C187785154 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5165199637413025 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q5464664 |
| concepts[6].display_name | Follicular phase |
| concepts[7].id | https://openalex.org/C3019258254 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4777630865573883 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1423317 |
| concepts[7].display_name | Second line |
| concepts[8].id | https://openalex.org/C2780739268 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4607819616794586 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2112244 |
| concepts[8].display_name | Progression-free survival |
| concepts[9].id | https://openalex.org/C198352243 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4436202049255371 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q37105 |
| concepts[9].display_name | Line (geometry) |
| concepts[10].id | https://openalex.org/C3019894029 |
| concepts[10].level | 2 |
| concepts[10].score | 0.42564207315444946 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q332823 |
| concepts[10].display_name | Overall survival |
| concepts[11].id | https://openalex.org/C2993493390 |
| concepts[11].level | 2 |
| concepts[11].score | 0.27616310119628906 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q5453208 |
| concepts[11].display_name | First line |
| concepts[12].id | https://openalex.org/C33923547 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q395 |
| concepts[12].display_name | Mathematics |
| concepts[13].id | https://openalex.org/C2524010 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q8087 |
| concepts[13].display_name | Geometry |
| concepts[14].id | https://openalex.org/C199539241 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[14].display_name | Law |
| concepts[15].id | https://openalex.org/C17744445 |
| concepts[15].level | 0 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[15].display_name | Political science |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.92855304479599 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/follicular-lymphoma |
| keywords[1].score | 0.8843040466308594 |
| keywords[1].display_name | Follicular lymphoma |
| keywords[2].id | https://openalex.org/keywords/front-line |
| keywords[2].score | 0.6959500312805176 |
| keywords[2].display_name | Front line |
| keywords[3].id | https://openalex.org/keywords/oncology |
| keywords[3].score | 0.652834951877594 |
| keywords[3].display_name | Oncology |
| keywords[4].id | https://openalex.org/keywords/lymphoma |
| keywords[4].score | 0.6028927564620972 |
| keywords[4].display_name | Lymphoma |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.5190427899360657 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/follicular-phase |
| keywords[6].score | 0.5165199637413025 |
| keywords[6].display_name | Follicular phase |
| keywords[7].id | https://openalex.org/keywords/second-line |
| keywords[7].score | 0.4777630865573883 |
| keywords[7].display_name | Second line |
| keywords[8].id | https://openalex.org/keywords/progression-free-survival |
| keywords[8].score | 0.4607819616794586 |
| keywords[8].display_name | Progression-free survival |
| keywords[9].id | https://openalex.org/keywords/line |
| keywords[9].score | 0.4436202049255371 |
| keywords[9].display_name | Line (geometry) |
| keywords[10].id | https://openalex.org/keywords/overall-survival |
| keywords[10].score | 0.42564207315444946 |
| keywords[10].display_name | Overall survival |
| keywords[11].id | https://openalex.org/keywords/first-line |
| keywords[11].score | 0.27616310119628906 |
| keywords[11].display_name | First line |
| language | en |
| locations[0].id | doi:10.2340/1651-226x.2024.24377 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S1043257 |
| locations[0].source.issn | 0284-186X, 1651-226X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0284-186X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Acta Oncologica |
| locations[0].source.host_organization | https://openalex.org/P4310320547 |
| locations[0].source.host_organization_name | Taylor & Francis |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320547 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://medicaljournalssweden.se/actaoncologica/article/download/24377/46021 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Acta Oncologica |
| locations[0].landing_page_url | https://doi.org/10.2340/1651-226x.2024.24377 |
| locations[1].id | pmid:38709114 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Acta oncologica (Stockholm, Sweden) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38709114 |
| locations[2].id | pmh:oai:ddd.uab.cat:302160 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400380 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) |
| locations[2].source.host_organization | https://openalex.org/I123044942 |
| locations[2].source.host_organization_name | Universitat Autònoma de Barcelona |
| locations[2].source.host_organization_lineage | https://openalex.org/I123044942 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Article |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://ddd.uab.cat/record/302160 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11332539 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Acta Oncol |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11332539 |
| locations[4].id | pmh:oai:doaj.org/article:ce557e7d205e449bb320adff8cfc7f23 |
| locations[4].is_oa | False |
| locations[4].source.id | https://openalex.org/S4306401280 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[4].source.host_organization | |
| locations[4].source.host_organization_name | |
| locations[4].source.host_organization_lineage | |
| locations[4].license | |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | article |
| locations[4].license_id | |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Acta Oncologica, Vol 63, Iss 1 (2024) |
| locations[4].landing_page_url | https://doaj.org/article/ce557e7d205e449bb320adff8cfc7f23 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5015725051 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1105-3549 |
| authorships[0].author.display_name | Aino Rajamäki |
| authorships[0].countries | FI |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I175532246 |
| authorships[0].affiliations[0].raw_affiliation_string | Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland |
| authorships[0].institutions[0].id | https://openalex.org/I175532246 |
| authorships[0].institutions[0].ror | https://ror.org/00cyydd11 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I175532246 |
| authorships[0].institutions[0].country_code | FI |
| authorships[0].institutions[0].display_name | University of Eastern Finland |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Aino Rajamaki |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland |
| authorships[1].author.id | https://openalex.org/A5004171353 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0587-591X |
| authorships[1].author.display_name | Marc Sorigué |
| authorships[1].affiliations[0].raw_affiliation_string | Medical Department, Trialing Health, Barcelona, Spain |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Marc Sorigue |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Medical Department, Trialing Health, Barcelona, Spain |
| authorships[2].author.id | https://openalex.org/A5047480864 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-8908-1542 |
| authorships[2].author.display_name | Roosa Prusila |
| authorships[2].countries | FI |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210092991 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland |
| authorships[2].institutions[0].id | https://openalex.org/I4210092991 |
| authorships[2].institutions[0].ror | https://ror.org/00fqdfs68 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210092991 |
| authorships[2].institutions[0].country_code | FI |
| authorships[2].institutions[0].display_name | Kuopio University Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Roosa E.I. Prusila |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland |
| authorships[3].author.id | https://openalex.org/A5047154150 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4435-4199 |
| authorships[3].author.display_name | Milla E.L. Kuusisto |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Internal Medicine, Länsi-Pohja Central Hospital, Kemi, Finland |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Milla E.L. Kuusisto |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Internal Medicine, Länsi-Pohja Central Hospital, Kemi, Finland |
| authorships[4].author.id | https://openalex.org/A5082053412 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7328-2043 |
| authorships[4].author.display_name | Hanne Kuitunen |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Internal Medicine, Länsi-Pohja Central Hospital, Kemi, Finland |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Hanne Kuitunen |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Internal Medicine, Länsi-Pohja Central Hospital, Kemi, Finland |
| authorships[5].author.id | https://openalex.org/A5112063935 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Esa Jantunen |
| authorships[5].countries | FI |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I175532246 |
| authorships[5].affiliations[0].raw_affiliation_string | Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I4210092991 |
| authorships[5].affiliations[1].raw_affiliation_string | Department of Medicine, Kuopio University Hospital, Kuopio, Finland |
| authorships[5].institutions[0].id | https://openalex.org/I4210092991 |
| authorships[5].institutions[0].ror | https://ror.org/00fqdfs68 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210092991 |
| authorships[5].institutions[0].country_code | FI |
| authorships[5].institutions[0].display_name | Kuopio University Hospital |
| authorships[5].institutions[1].id | https://openalex.org/I175532246 |
| authorships[5].institutions[1].ror | https://ror.org/00cyydd11 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I175532246 |
| authorships[5].institutions[1].country_code | FI |
| authorships[5].institutions[1].display_name | University of Eastern Finland |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Esa Jantunen |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Medicine, Kuopio University Hospital, Kuopio, Finland, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland |
| authorships[6].author.id | https://openalex.org/A5015394751 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-4741-7885 |
| authorships[6].author.display_name | Santiago Mercadal |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210143012 |
| authorships[6].affiliations[0].raw_affiliation_string | ICO-Hospital Duran I Reynals, L'Hospitalet, Spain |
| authorships[6].institutions[0].id | https://openalex.org/I4210143012 |
| authorships[6].institutions[0].ror | https://ror.org/03qwghy04 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210143012 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Duran i Reynals Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Santiago Mercadal |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | ICO-Hospital Duran I Reynals, L'Hospitalet, Spain |
| authorships[7].author.id | https://openalex.org/A5006535775 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Taina Turpeenniemi‐Hujanen |
| authorships[7].countries | FI |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I2799272722, https://openalex.org/I98381234 |
| authorships[7].affiliations[0].raw_affiliation_string | Medical Research Center, Oulu University Hospital and Translational Medicine Research Unit, University of Oulu, Oulu, Finland |
| authorships[7].institutions[0].id | https://openalex.org/I2799272722 |
| authorships[7].institutions[0].ror | https://ror.org/045ney286 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I2799272722 |
| authorships[7].institutions[0].country_code | FI |
| authorships[7].institutions[0].display_name | Oulu University Hospital |
| authorships[7].institutions[1].id | https://openalex.org/I98381234 |
| authorships[7].institutions[1].ror | https://ror.org/03yj89h83 |
| authorships[7].institutions[1].type | education |
| authorships[7].institutions[1].lineage | https://openalex.org/I98381234 |
| authorships[7].institutions[1].country_code | FI |
| authorships[7].institutions[1].display_name | University of Oulu |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Taina Turpeenniemi-Hujanen |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Medical Research Center, Oulu University Hospital and Translational Medicine Research Unit, University of Oulu, Oulu, Finland |
| authorships[8].author.id | https://openalex.org/A5083191976 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7168-6538 |
| authorships[8].author.display_name | Juan‐Manuel Sancho |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210153460 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Hematology, ICO-Hospital Germans Trias i Pujol, IJC, UAB, Badalona, Barcelona, Spain |
| authorships[8].institutions[0].id | https://openalex.org/I4210153460 |
| authorships[8].institutions[0].ror | https://ror.org/04wxdxa47 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I4210153292, https://openalex.org/I4210153460 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Hospital Universitari Germans Trias i Pujol |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Juan-Manuel Sancho |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Hematology, ICO-Hospital Germans Trias i Pujol, IJC, UAB, Badalona, Barcelona, Spain |
| authorships[9].author.id | https://openalex.org/A5046452137 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-2639-5448 |
| authorships[9].author.display_name | Kaisa Sunela |
| authorships[9].affiliations[0].raw_affiliation_string | Finnish Medicines Agency FIMEA, Barcelona, Spain |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Kaisa Sunela |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Finnish Medicines Agency FIMEA, Barcelona, Spain |
| authorships[10].author.id | https://openalex.org/A5019774051 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-9969-0053 |
| authorships[10].author.display_name | Outi Kuittinen |
| authorships[10].countries | FI |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210092991 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Oncology, Kuopio University Hospital, Kuopio, Finland |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I175532246 |
| authorships[10].affiliations[1].raw_affiliation_string | Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland |
| authorships[10].affiliations[2].institution_ids | https://openalex.org/I2799272722, https://openalex.org/I98381234 |
| authorships[10].affiliations[2].raw_affiliation_string | Medical Research Center, Oulu University Hospital and Translational Medicine Research Unit, University of Oulu, Oulu, Finland |
| authorships[10].institutions[0].id | https://openalex.org/I4210092991 |
| authorships[10].institutions[0].ror | https://ror.org/00fqdfs68 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210092991 |
| authorships[10].institutions[0].country_code | FI |
| authorships[10].institutions[0].display_name | Kuopio University Hospital |
| authorships[10].institutions[1].id | https://openalex.org/I2799272722 |
| authorships[10].institutions[1].ror | https://ror.org/045ney286 |
| authorships[10].institutions[1].type | healthcare |
| authorships[10].institutions[1].lineage | https://openalex.org/I2799272722 |
| authorships[10].institutions[1].country_code | FI |
| authorships[10].institutions[1].display_name | Oulu University Hospital |
| authorships[10].institutions[2].id | https://openalex.org/I175532246 |
| authorships[10].institutions[2].ror | https://ror.org/00cyydd11 |
| authorships[10].institutions[2].type | education |
| authorships[10].institutions[2].lineage | https://openalex.org/I175532246 |
| authorships[10].institutions[2].country_code | FI |
| authorships[10].institutions[2].display_name | University of Eastern Finland |
| authorships[10].institutions[3].id | https://openalex.org/I98381234 |
| authorships[10].institutions[3].ror | https://ror.org/03yj89h83 |
| authorships[10].institutions[3].type | education |
| authorships[10].institutions[3].lineage | https://openalex.org/I98381234 |
| authorships[10].institutions[3].country_code | FI |
| authorships[10].institutions[3].display_name | University of Oulu |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Outi Kuittinen |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Oncology, Kuopio University Hospital, Kuopio, Finland, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland, Medical Research Center, Oulu University Hospital and Translational Medicine Research Unit, University of Oulu, Oulu, Finland |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://medicaljournalssweden.se/actaoncologica/article/download/24377/46021 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T06:51:31.235846 |
| primary_topic.id | https://openalex.org/T10185 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Lymphoma Diagnosis and Treatment |
| related_works | https://openalex.org/W4361884913, https://openalex.org/W2946863839, https://openalex.org/W3016049727, https://openalex.org/W2481713064, https://openalex.org/W4390128515, https://openalex.org/W4293087849, https://openalex.org/W4387004025, https://openalex.org/W1912259233, https://openalex.org/W1982290871, https://openalex.org/W4307871220 |
| cited_by_count | 0 |
| locations_count | 5 |
| best_oa_location.id | doi:10.2340/1651-226x.2024.24377 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S1043257 |
| best_oa_location.source.issn | 0284-186X, 1651-226X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0284-186X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Acta Oncologica |
| best_oa_location.source.host_organization | https://openalex.org/P4310320547 |
| best_oa_location.source.host_organization_name | Taylor & Francis |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320547 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://medicaljournalssweden.se/actaoncologica/article/download/24377/46021 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Acta Oncologica |
| best_oa_location.landing_page_url | https://doi.org/10.2340/1651-226x.2024.24377 |
| primary_location.id | doi:10.2340/1651-226x.2024.24377 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S1043257 |
| primary_location.source.issn | 0284-186X, 1651-226X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0284-186X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Acta Oncologica |
| primary_location.source.host_organization | https://openalex.org/P4310320547 |
| primary_location.source.host_organization_name | Taylor & Francis |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320547 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://medicaljournalssweden.se/actaoncologica/article/download/24377/46021 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Acta Oncologica |
| primary_location.landing_page_url | https://doi.org/10.2340/1651-226x.2024.24377 |
| publication_date | 2024-05-06 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3022928951, https://openalex.org/W3157226561, https://openalex.org/W2917252593, https://openalex.org/W4223934984, https://openalex.org/W4249178543, https://openalex.org/W4254151655, https://openalex.org/W2412412094, https://openalex.org/W2965192391, https://openalex.org/W4319317718, https://openalex.org/W3085880801, https://openalex.org/W4292229870, https://openalex.org/W2141681661, https://openalex.org/W2902226821, https://openalex.org/W3043738734, https://openalex.org/W2795961656, https://openalex.org/W1885678484, https://openalex.org/W3198548668, https://openalex.org/W2762911675, https://openalex.org/W4298088050, https://openalex.org/W1970648523, https://openalex.org/W2121101566, https://openalex.org/W1588030529, https://openalex.org/W4293203547, https://openalex.org/W3128835774, https://openalex.org/W1456239636, https://openalex.org/W2005579966, https://openalex.org/W2761878534, https://openalex.org/W4255164806, https://openalex.org/W2895212757, https://openalex.org/W2963759094, https://openalex.org/W2118097985, https://openalex.org/W1570249624, https://openalex.org/W2160093471, https://openalex.org/W4321613753, https://openalex.org/W4293796458, https://openalex.org/W2999786719, https://openalex.org/W2906575149, https://openalex.org/W2505010070, https://openalex.org/W3108026732, https://openalex.org/W1554787345, https://openalex.org/W2118826067, https://openalex.org/W2145745667, https://openalex.org/W2061272096, https://openalex.org/W2124432094, https://openalex.org/W2599076725, https://openalex.org/W4391271014 |
| referenced_works_count | 46 |
| abstract_inverted_index.= | 49 |
| abstract_inverted_index.a | 10, 135, 150 |
| abstract_inverted_index.(n | 48 |
| abstract_inverted_index.60 | 54 |
| abstract_inverted_index.CI | 97 |
| abstract_inverted_index.FL | 61, 180 |
| abstract_inverted_index.It | 189 |
| abstract_inverted_index.We | 19, 100, 133 |
| abstract_inverted_index.at | 146 |
| abstract_inverted_index.be | 191 |
| abstract_inverted_index.by | 183 |
| abstract_inverted_index.in | 66, 168 |
| abstract_inverted_index.is | 181 |
| abstract_inverted_index.of | 12, 35, 40, 154, 179 |
| abstract_inverted_index.on | 37 |
| abstract_inverted_index.or | 158, 166 |
| abstract_inverted_index.to | 22, 193 |
| abstract_inverted_index.(1) | 105 |
| abstract_inverted_index.(2) | 107 |
| abstract_inverted_index.(3) | 110 |
| abstract_inverted_index.(4) | 118 |
| abstract_inverted_index.(5) | 126 |
| abstract_inverted_index.(6) | 130 |
| abstract_inverted_index.2.2 | 94 |
| abstract_inverted_index.4.2 | 87 |
| abstract_inverted_index.51% | 51 |
| abstract_inverted_index.8.1 | 79 |
| abstract_inverted_index.CI: | 90 |
| abstract_inverted_index.The | 1, 72 |
| abstract_inverted_index.age | 145 |
| abstract_inverted_index.and | 17, 32, 44, 64, 76, 93, 125, 129 |
| abstract_inverted_index.can | 198 |
| abstract_inverted_index.did | 161 |
| abstract_inverted_index.for | 5, 104, 138 |
| abstract_inverted_index.low | 122 |
| abstract_inverted_index.new | 196 |
| abstract_inverted_index.not | 162 |
| abstract_inverted_index.out | 21 |
| abstract_inverted_index.see | 194 |
| abstract_inverted_index.set | 20 |
| abstract_inverted_index.the | 38, 176 |
| abstract_inverted_index.who | 140 |
| abstract_inverted_index.(95% | 81, 89, 96 |
| abstract_inverted_index.(FL) | 8 |
| abstract_inverted_index.1997 | 63 |
| abstract_inverted_index.2016 | 65 |
| abstract_inverted_index.743, | 50 |
| abstract_inverted_index.PFS1 | 103 |
| abstract_inverted_index.PFS2 | 137, 165 |
| abstract_inverted_index.PFS3 | 77, 167 |
| abstract_inverted_index.With | 172 |
| abstract_inverted_index.age, | 109 |
| abstract_inverted_index.each | 187 |
| abstract_inverted_index.line | 34 |
| abstract_inverted_index.nine | 67 |
| abstract_inverted_index.old) | 56 |
| abstract_inverted_index.this | 169, 200 |
| abstract_inverted_index.were | 69, 78 |
| abstract_inverted_index.will | 190 |
| abstract_inverted_index.with | 58, 149, 164 |
| abstract_inverted_index.(PFS) | 26 |
| abstract_inverted_index.(over | 121 |
| abstract_inverted_index.1–2 | 60 |
| abstract_inverted_index.Older | 144 |
| abstract_inverted_index.PFS1, | 74 |
| abstract_inverted_index.PFS2, | 75 |
| abstract_inverted_index.PFS3. | 152 |
| abstract_inverted_index.POD24 | 159 |
| abstract_inverted_index.[CI]: | 84 |
| abstract_inverted_index.after | 27, 186 |
| abstract_inverted_index.alter | 199 |
| abstract_inverted_index.basis | 39 |
| abstract_inverted_index.found | 101, 134 |
| abstract_inverted_index.front | 28 |
| abstract_inverted_index.grade | 59 |
| abstract_inverted_index.index | 116 |
| abstract_inverted_index.line, | 29, 31 |
| abstract_inverted_index.third | 33 |
| abstract_inverted_index.years | 55, 80, 88, 95 |
| abstract_inverted_index.course | 178 |
| abstract_inverted_index.highly | 13 |
| abstract_inverted_index.longer | 102 |
| abstract_inverted_index.median | 53, 73 |
| abstract_inverted_index.number | 11 |
| abstract_inverted_index.second | 30 |
| abstract_inverted_index.status | 160 |
| abstract_inverted_index.years) | 92 |
| abstract_inverted_index.7–9.3 | 85 |
| abstract_inverted_index.between | 62 |
| abstract_inverted_index.current | 173 |
| abstract_inverted_index.natural | 177 |
| abstract_inverted_index.shorter | 136, 151 |
| abstract_inverted_index.therapy | 36 |
| abstract_inverted_index.whether | 195 |
| abstract_inverted_index.years), | 86 |
| abstract_inverted_index.years). | 99 |
| abstract_inverted_index.younger | 108 |
| abstract_inverted_index.(FLIPI), | 117 |
| abstract_inverted_index.Patients | 16, 47 |
| abstract_inverted_index.Results: | 71 |
| abstract_inverted_index.choices. | 46 |
| abstract_inverted_index.dataset. | 170 |
| abstract_inverted_index.females, | 52, 106 |
| abstract_inverted_index.includes | 9 |
| abstract_inverted_index.interval | 83 |
| abstract_inverted_index.lymphoma | 7, 113 |
| abstract_inverted_index.methods: | 18 |
| abstract_inverted_index.patients | 139 |
| abstract_inverted_index.pattern. | 201 |
| abstract_inverted_index.received | 141 |
| abstract_inverted_index.regimens | 124 |
| abstract_inverted_index.relapse. | 188 |
| abstract_inverted_index.relevant | 41 |
| abstract_inverted_index.standard | 119 |
| abstract_inverted_index.survival | 25 |
| abstract_inverted_index.1.7–2.8 | 98 |
| abstract_inverted_index.2.8–5.6 | 91 |
| abstract_inverted_index.Intensity | 153 |
| abstract_inverted_index.correlate | 163 |
| abstract_inverted_index.determine | 23 |
| abstract_inverted_index.diagnosed | 57 |
| abstract_inverted_index.diagnosis | 147 |
| abstract_inverted_index.effective | 14 |
| abstract_inverted_index.included. | 70 |
| abstract_inverted_index.intensity | 120 |
| abstract_inverted_index.landscape | 4 |
| abstract_inverted_index.therapies | 197 |
| abstract_inverted_index.biological | 42 |
| abstract_inverted_index.confidence | 82 |
| abstract_inverted_index.correlated | 148 |
| abstract_inverted_index.follicular | 6, 112 |
| abstract_inverted_index.front-line | 142, 155 |
| abstract_inverted_index.intensity) | 123 |
| abstract_inverted_index.lower-risk | 111 |
| abstract_inverted_index.modern-day | 2 |
| abstract_inverted_index.prognostic | 115 |
| abstract_inverted_index.remissions | 185 |
| abstract_inverted_index.rituximab. | 132 |
| abstract_inverted_index.strategies | 128 |
| abstract_inverted_index.therapies. | 15 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.interesting | 192 |
| abstract_inverted_index.maintenance | 131 |
| abstract_inverted_index.strategies, | 175 |
| abstract_inverted_index.therapeutic | 3, 45 |
| abstract_inverted_index.institutions | 68 |
| abstract_inverted_index.maintenance, | 157 |
| abstract_inverted_index.characterized | 182 |
| abstract_inverted_index.chemotherapy, | 156 |
| abstract_inverted_index.international | 114 |
| abstract_inverted_index.Interpretation: | 171 |
| abstract_inverted_index.characteristics | 43 |
| abstract_inverted_index.shorter-lasting | 184 |
| abstract_inverted_index.progression-free | 24 |
| abstract_inverted_index.immunochemotherapy | 127, 174 |
| abstract_inverted_index.immunochemotherapy. | 143 |
| cited_by_percentile_year | |
| countries_distinct_count | 2 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.41999998688697815 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.11860574 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |